School of Public Health > News > Dietary Intake or Dietary Supplementation of Antioxidant Vitamins Does Not Reduce Risk of Prostate Cancer


News

About the School
of Public Health

Admissions

Faculty directory

Academic programs

Research programs

Student Services

Ph.D. & M.S. Graduate Program

Public Health Library

Alumni

News

Public Health Practice

Support the School

Calendar

Faculty and
Postdoctoral
Positions

Site directory

Contact us

Visiting Campus

Search

News Archives

Slideshows

YSPH Press Releases

YSPH in the News

YSPH Opinion/Commentary

YSPH Podcasts

Yale Public Health Magazine

Dietary Intake or Dietary Supplementation of Antioxidant Vitamins Does Not Reduce Risk of Prostate Cancer

  Elizabeth Bradley.
  Vitamin E does not reduce the risk of prostate cancer but high-dose supplements may reduce the risk in smokers, according to a study published in the Journal of the National Cancer Institute, co-authored by Susan Mayne, professor of epidemiology in the Division of Chronic Disease Epidemiology.

Males who consume vitamin E, Beta-carotene, and vitamin C by either dietary intake or supplementation do not lower their risk of prostate cancer, a group of researchers reported in the Journal of National Cancer Institute. The research team was led by former Yale School of Public Health (YSPH) doctoral student Victoria Kirsh, Ph.D., who conducted the research as part of her dissertation and is now a junior scientist at Cancer Care Ontario. The researchers reported that while there was no significant association between the use of antioxidant supplementation and the reduced risk of prostate cancer, there was an association between high-dose supplemental vitamin E intake and a reduced risk of prostate cancer in smokers.

“There has been definite interest in the use of antioxidant micronutrients to help reduce the risk of cancer,” said Kirsh. “In keeping with the results of previous trials, vitamin E supplementation was related to a reduced risk of prostate cancer in smokers, although the reasons for that benefit remain unclear since smoking itself is not strongly related to prostate cancer.”

“The study is unique in that it was carried out in the screening arm of a randomized trial to evaluate Prostate-Specific Antigen test (PSA) and digital rectal examination (DRE) as prostate cancer modalities,” Kirsh stated. This helped to avoid bias that could result from men with healthier diets seeking prostate screening examinations.

Kirsh conducted the study in collaboration with Susan Mayne, Ph.D., professor of epidemiology in the Division of Chronic Disease Epidemiology at YSPH, and investigators at the National Cancer Institute (NCI) as part of the Yale University – National Cancer Institute Partnership Training Program. The Training Program is the only one of its kind and is designed to support students while they train in modern methodologies for evaluating lifestyle determinants of human cancer risk, with an emphasis on nutritional, environmental, and occupational determinants, including their interactions with genetic factors.

Other researchers include Richard B. Hayes, Ph.D., Nilanjan Chatterjee, Ph.D., Amy F. Subar, Ph.D., L. Beth Dixon, Ph.D., Demetrius Albanes, M.D., Gerald L. Andriole, M.D., Donald A. Urban, M.D., and Ulrike Peters, Ph.D.

Citation: Journal of the National Cancer Institute, 98(4): 245-254, 2006.

— Story by Marcie Foley

Yale University  |  Medical School Library  |  Yale School of Medicine Info |   EPH Administration (restricted)

Yale School of Public Health  |  60 College Street  |  P.O. Box 208034  |  New Haven, CT 06520.8034

Copyright © 2006, Yale School of Public Health, New Haven, Connecticut, USA.
All rights reserved. Comments or suggestions to site editor. Site designed by ITS-Med Web Design & Development.

Last modified: March 3, 2006 [LMc.]